Insulin aspart, recombinant Subcutaneous and Oramorph SR
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Oramorph SR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Oramorph SR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Orap
- Insulin aspart, recombinant Subcutaneous-Orapred
- Insulin aspart, recombinant Subcutaneous-Orapred ODT
- Insulin aspart, recombinant Subcutaneous-Oraqix
- Insulin aspart, recombinant Subcutaneous-Orasol
- Insulin aspart, recombinant Subcutaneous-OraVerse
- Oramorph SR-Insulin degludec
- Oramorph SR-Insulin Degludec (U-100) Prefilled Pens
- Oramorph SR-Insulin Degludec (U-100) Vials
- Oramorph SR-Insulin Degludec (U-200) Prefilled Pens
- Oramorph SR-Insulin degludec and liraglutide
- Oramorph SR-Insulin degludec and liraglutide Subcutaneous